Lentivirus replication and regulation

Annual Review of Genetics

Volumn 33, Issue , 1999, Pages 133-170

  Tang, Hengli ^a   Kuhen, Kelli L ^a   Wong Staal, Flossie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Downregulation; Human immunodeficiency virus; Posttranscriptional control; Retrovirus; Transcriptional regulation

Indexed keywords

VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PROCESSING; RETROVIRUS; REVIEW; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; GENE PRODUCTS, TAT; HIV-1; HUMANS; LENTIVIRUS; LENTIVIRUS INFECTIONS; MOLECULAR SEQUENCE DATA; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0033389871     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.33.1.133     Document Type: Review

References (275)

1. 1. Aiken C. 1998. Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity. Virology 248:139-47
2. 2. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-64
3. 3. Aiken C, Trono D. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048-56
4. 4. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, et al. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-58
5. 5. Alonso A, Cujec T, Peterlin BM. 1994. Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J. Virol. 68:6505-13
6. 6. Arrigo SJ, Chen IS. 1991. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif vpr and env/vpu 2 RNAs. Genes Dev. 5:808-19
7. 7. Arrigo SJ, Heaphy S, Haines JK. 1992. In vivo binding of wild-type and mutant human immunodeficiency virus type 1 Rev proteins: implications for function. J. Virol. 66(9):5569-75
8. 8. Atchinson ML, Perry RP. 1987. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription. Cell 48: 121-28
9. 9. Baeurle PA, Henkel T. 1994. Function and activation of NF-ΚB in the immune system. Annu. Rev. Immunol. 12:141-79
10. 10. Bai X, Chen JD, Yang AG, Torti F, Chen SY. 1998. Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Gene Therapy 5:984-94
11. 11. Bartel DP, Zapp ML, Green MR, Szostak JW. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-36
12. 12. Bartz SR, Rogel ME, Emerman M. 1996. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage check-point control. J. Virol. 70:2324-31
13. 13. Battiste JL, Tan R, Frankel AD, Williamson JR. 1994. Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs. Biochemistry 33:2741-47
14. 14. Berger EA. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11:(Suppl. A):S3-16
15. 15. Bevec D, Jaksche H, Oft M, Wöhl T, Himmelspach M, et al. 1996. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 271:1858-60
16. 16. Bleul CC, Farzan M, Choe H, Parolin C, Clarke-Lewis I, et al. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-33
17. 17. Bogerd HP, Fridell RA, Madore S, Cullen BR. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-94
18. 18. Braaten D, Aberham C, Franke EK, Yin L, Phares W, Luban J. 1996. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J. Virol. 70:5170-76
19. 19. Braaten D, Franke EK, Luban J. 1996. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol. 70:4220-27
20. 20. Brand SR, Kobayashi R, Mathews MB. 1997. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272:8388-95
21. 21. Bray M, Prasad S, Dubay JW, Hunter E, Jeang KT, et al. 1994. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 91:1256-60
22. 22. Brown DA, Xu X, Nerenberg M. Genomic footprinting of HTLV type 1 and HIV type 1 in human T cell lines. AIDS Res. Hum. Retroviruses 12:829-32
23. 23. Bryant M, Ratner L. 1990. Myristylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-27
24. 24. Bukovsky A, Weimann A, Accola MA, Gottlinger HG. 1997. Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc. Natl. Acad. Sci. USA 94:10943-48
25. 25. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall TE, Lewis RE, Stevenson M. 1996. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93:367-71
26. 26. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, et al. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89: 6580-84
27. 27. Buratowski S, Hahn S, Guarente L, Sharp PA. 1989. Five intermediate complexes in transcription initiation by RNA polymerase II. Cell 56:549-61
28. 28. Campbell LH, Borg KT, Haines JK, Moon RT, Schoenberg DR, et al. 1994. Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J. Virol. 68:5433-38
29. 29. Carillo A, Ratner L. 1996. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells. J. Virol. 70:1310-16
30. 30. Cartier C, Deckert M, Grangeasse C, Trauger R, Jensen F, et al. 1997. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J. Virol. 71:4832-37
31. 31. Chan DC, Fass D, Berger JM, Kim PS. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-73
32. 32. Chang DD, Sharp PA. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789-95
33. 33. Chen H, Engelman A. 1998.The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. USA 95:15270-74
34. 34. Chesebro B, Nishio J, Perryman S, Cann A, O'Brien W, et al. 1991. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J. Virol. 65:5782-89
35. 35. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, et al. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-48
36. 36. Chun RF, Semmes OJ, Neuveut C, Jeang KT. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-29
37. 37. Churcher MJ, Lamont C, Hamy F, Dingwall C, Green S. 1993. High affinity binding of TAR RNA by the human immunodeficiency virus Type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 230:90-110
38. 38. Clapham PR. 1997. HIV and chemokines: ligands sharing cell-surface receptors. Trends Cell Biol. 7:264-68
39. 39. Clements JE, Wong-Staal F. 1992. Molecular biology of lentiviruses. Semin. Virol. 3:137-46
40. + T cells. Science 270:1811-15
41. 41. Cocchi F, DeVico AL, Garzinodemo A, Cara A, Gallo RC, et al. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-47
42. 42. Coffin J, Hughes S, Varmus H. eds. 1997. Retroviruses. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
43. 43. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401
44. 44. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-21
45. 45. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. 1997. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621-28
46. 46. Cooney AJ, Tsai SY, O'Malley BW, Tsai MJ. 1991. Chicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 62:2853-60
47. 47. Cordonnier A, Montagnier L, Emerman M. 1989. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature 340:571-74
48. 48. Deleted in proof
49. 49. Craig HM, Pandori MW, Guatelli JC. 1998. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. USA 95:11229-34
50. 50. Cullen BR. 1998. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93:685-92
51. 51. Dalgleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-68
52. 52. Deleted in proof
53. 53. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Cohort Study, San Francisco Cohort, ALIVE Study. Science 273:1856-62
54. 54. Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, et al. 1994. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children [letter] Blood 83:3101-03
55. 55. Deng HK, Liu R, Ellmeier W, Choe S, Unutmaz D, et al. 1996. Identification of a major co-receptor for primary isolates of HTV-1. Nature 381:661-66
56. 56. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR. 1995. Mutational analysis of cell cycle arrest nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. (12):7909-16
57. 57. Donello JE, Beeche AA, Smith GJ 3rd, Lucero GR, Hope TJ. 1996. The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J. Virol. 70:4345-51
58. 58. Doranz BJ, Rucker J, Yi YJ, Smyth RJ, Samson M, et al. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-58
59. 59. Dragic T, Litwin V, Allaway GP, Martin SR, Huang YX, et al. 1996. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-73
60. 60. Du H, Roy AL, Roeder RG. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:501-11
61. 61. Earl PL, Doms RW, Moss B. 1990. Oligomeric strucutre of the human immunodefeciency type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87:648-52
62. 62. Earl PL, Moss B, Doms RW. 1991. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol 65:2047-55
63. 63. El Kharroubi A, Martin MA. 1996. Cisacting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-66
64. 64. El Kharroubi A, Verdin E. 1994. Protein-DNA interactions within Dnase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269: 19916-24
65. 65. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, et al. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-56
66. 66. Ernst RK, Bray M, Rekosh D, Hammarskjold ML. 1997. Secondary structure and mutational analysis of the Mason-Pfizer monkey virus RNA constitutive transport element. RNA 3:210-22
67. 67. Ernst RK, Bray M, Rekosh D, Hammarskjöld ML. 1997. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17:135-44
68. 68. Esposito D, Craigie R. 1998. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 17:5832-43
69. 69. Farzan M, Choe H, Vaca L, Martin K, Ying S, et al. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-64
70. 70. Feng S, Holland EC. 1988. HIV-1 tat transactivation requires the loop sequences within TAR. Nature 334:165-67
71. 71. Feng Y, Broder CC, Kennedy PE, Berger EA. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-77
72. 72. Fischer U, Huber J, Boelens WC, Mattaj IW, Lührmann R. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-83
73. 73. Fletcher TM 3rd, Brichacek B, Sharova N, Newman MA, Stivahtis G, et al. 1996. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J. 15:6155-65
74. 74. Forget J, Yao XJ, Mercier J, Cohen EA. 1998. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. J. Mol. Biol. 284:915-23
75. 75. Fornerod M, Ohno M, Yoshida M, Mattaj IW. 1997. CRM-1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-60
76. 76. Fouchier RA, Meyer BE, Simon JH, Fischer U, Albright AV, et al. 1998. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72:6004-13
77. 77. Fouchier RA, Simon JH, Jaffe AB, Malim MH. 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70:8263-69
78. 78. Franza BR, Raucher FJ, Josephs SP, Curran T. 1988. The fos complex and fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239:1150-53
79. 79. Fritz CC, Zapp ML, Green MR. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376:530-33
80. 80. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, et al. 1997. CRM-1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390:308-11
81. 81. Gallay P, Hope T, Chin D, Trono D. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Nat. Acad. Sci. USA 94(18):9825-30
82. 82. Gallay P, Swingler S, Aiken C, Trono D. 1995.HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-88
83. 83. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, et al. 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-94
84. + T cells by a Fas-independent mechanism. J. Exp. Med. 187:1113-22
85. 85. Garber ME, Wei P, Kewal Ramani VN, Mayall TP, Herrmann CH, et al. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-27
86. 86. Garcia JV, Miller AD. 1991. Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef. Nature 350:508-11
87. 87. Deleted in proof
88. 88. Deleted in proof
89. 89. Gaynor RB. 1995. Regulation of HIV-1 gene expression by the transactivator protein tat. In Transacting Functions of Human Retroviruses, ed. A Srinivasan, PK Vogt, pp. 51-79. Heidelberg: Springer-Verlag
90. 90. Gheysen D, Jacobs E, de Foresta F, Thiriart C, Francotte M, et al. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-12
91. 91. Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, et al. 1998. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72:3351-61
92. 92. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, et al. 1998. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 4:65-71
93. 93. Goila R, Banerjea AC. 1998. Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme. FEBS Lett. 436:233-38
94. 94. Gold MO, Yang X, Herrmann CH, Rice AP. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72:4448-53
95. 95. Gonzalez MA, Serrano F, Llorente M, Abad JL, Garcia-Ortiz MJ, Bernad A. 1998. A hammerhead ribozyme targeted to the human chemokine receptor CCR5. Biochem. Biophys. Res. Commun. 251:592-96
96. 96. Göttlinger HG, Sodroski JG, Haseltine WA. 1989. Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-85
97. 97. Grana X, De Luca A, Sang N, Fu Y, Claudio P, et al. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA 91:3834-38
98. 98. Greenberg ME, Bronson S, Lock M, Neumann M, Pavlakis GN, et al. 1997. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16:6964-76
99. 99. Greenberg M, DeTulleo L, Rapoport I, Skowronski J, Kirchhausen T. 1998. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr. Biol. 8:1239-42
100. 100. Greenberg ME, Iafrate AJ, Skowronski J. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class IMHC complexes. EMBO J. 17:2777-89
101. 101. Grüter P, Tabernero C, von Kobbe C, Schmitt C, Saavedra C, et al. 1998. TAP the human homolog of Mex67p mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1:649-59
102. 102. Guermah M, Malik S, Roeder RG. 1998. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Spl. Mol. Cell. Biol. 18:3234-44
103. 103. Gunnery S, Rice AP, Robertson HD, Mathews MB. 1990. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87:8687-91
104. 104. Guo B, Odgren PR, Wijnen VAJ, Last TJ, Nickerson J, et al. 1995. The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. USA 92:10526-30
105. 105. Hart C, Galphin J, Westhafer M, Schochetman G. 1993. TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J. Virol. 67:5020-24
106. 106. Hart C, Ou C, Galphin J, Moore J, Bacheler J, et al. 1989. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 246:488-91
107. 107. He J, Choe S, Walker R, Di Marzio P, Morgan DO, et al. 1995. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705-11
108. 108. He JL, Chen YZ, Farzan M, Choe HY, Ohagen A, et al. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-49
109. 109. Henderson BR, Percipalle P. 1997. Interactions between HIV Rev and nuclear import and export factors: the Rev nuclear localization signal mediates specific binding to human importin-beta. J. Mol. Biol. 274:693-707
110. 110. Herrmann CH, Rice A. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-20
111. 111. Hill CM, Littman DR. 1996. Natural resistance to HIV? Nature 382:668-69
112. 112. Hoover T, Mikovits J, Court D, Liu YL, Kung HF, Raziuddin. 1996. A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activity. Nucleic Acids Res. 24:1895-900
113. 113. Howcroft TK, Strebel K, Martin MA, Singer DS. 1993. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320-22
114. 114. Huang J, Liang TJ. 1993. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol. Cell. Biol. 13:7476-86
115. 115. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-43
116. 116. Huang ZM, Yen TS. 1995. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol. Cell. Biol. 15(7):3864-69
117. 117. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. 1991. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74
118. 118. Ivanov V, Stein B, Baumann I, Dobbelaere DA, Herrlich P, Williams RO. 1989. Infection with the intracellular protozoan parasite Theileria parva induces constitutively high levels of NF-kappa B in bovine T lymphocytes. Mol. Cell. Biol. 9:4677-86
119. 119. Jacque JM, Mann A, Enslen H, Sharova N, Brichacek B. 1998. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17:2607-18
120. 120. Jaeger JA, Tinoco I. 1993. An NMR study of the HIV-1 TAR element hairpin. Biochemistry 32:12522-30
121. 121. Jenkins Y, McEntee M, Weis K, Greene WC. 1998. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143:875-85
122. 122. Jones KA, Kadonago JT, Luciw PA, Tjian R. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor Spl. Science 232:755-59
123. 123. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, et al. 1995. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:6304-13
124. 124. Junker U, Bevec D, Barske C, Kalfoglou C, Escaich S, et al. 1996. Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study. Hum. Gene Ther. 7(15):1861-69
125. 125. Karni O, Friedler A, Zakai N, Gilon C, Loyter A. 1998. A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr. FEBS Lett. 429:421-25
126. 126. Katze MG. 1995. Regulation of the interferon-induced PKR: Can viruses cope? Trends Microbiol. 3:75-78
127. 127. Kerkau T, Bacik I, Bennink JR, Yewdell JW, Húnig T, et al. 1997. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 185:1295-305
128. 128. Deleted in proof
129. 129. Kingsman SM, Kingsman AJ. 1996. The regulation human of immunodeficiency virus type-1 gene expression. Eur. J. Biochem. 240:491-507
130. 130. Deleted in proof
131. 131. Kjems J, Sharp PA. 1993. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:4769-76
132. 132. Kwong PD, Wyatt R, Robinson J, Sweet R, Sodroski J, Hendrickson WA. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing antibody. Nature 393:648-59
133. 133. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, et al. 1987. Delineation of the region of the human immunodeficiency virus gp 120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-85
134. 134. Laspia MF, Rice A, Mathews MB. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-92
135. 135. Laughlin MA, Pomerantz RJ. 1994. Cellular latency in HIV-1 infection. Clin. Lab. Med. 14:239-55
136. 136. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, et al. 1998. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8:483-95
137. 137. Lewis PF, Emerman M. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510
138. 138. Lewis PF, Hensel M, Emerman M. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:3053-58
139. 139. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-31
140. 140. Li J, Tang H, Mullen TM, Westberg C, Reddy TR, Rose DW, Wong-Staal F. 1999. A role for RNA helicase A in posttranscriptional regulation of HIV type 1. Proc. Natl. Acad. Sci. USA 96:709-14
141. 141. Liang C, Li X, Quan Y, Laughrea M, Kleiman L, et al. 1997. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription. J. Mol. Biol. 272:167-77
142. 142. Liu R, Paxton WA, Choe S, Ceradini D, Martin S, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-77
143. 143. Liu X, Mertz JE. 1995. HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression. Genes Dev. 9:1766-80
144. 144. Liu YZ, Latchman DS. 1997. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat. Biochem. J. 322:155-58
145. 145. Lu Y, Stenzel M, Sodroski J, Haseltine WA. 1989. Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication. J. Virol. 62:4115-19
146. 146. Lu YC, Touzjian N, Stenzel M, Dorfman T, Sodroski J, Haseltine WA. 1990. Identification of cis-acting repressive sequences within the negative regulatory element human immunodeficiency virus type 1. J. Virol. 64:5226-29
147. 147. Lucotte G. 1997. Frequencies of the CC chemokine receptor 5 delta 32 allele in various populations of defined racial background. Biomed. Pharmacother. 51: 469-73
148. 148. Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Weiner DB. 1997. Nuclear import virion incorporation and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71:6339-47
149. 149. Malim MH, Böhnlein S, Hauber J, Cullen BR. 1989. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell 58:205-14
150. 150. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. 1989. The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-57
151. 151. Mallardo M, Dragonetti E, Baldassarre F, Ambrosino C, Scala G, Quinto I. 1996. An NF-kappaB site in the 5′-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli. J. Biol. Chem. 271:20820-27
152. 152. Mancebo H, Lee G, Flygare J, Tomassini J, Luu P, et al. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633-44
153. 153. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier JL, et al. 1997. The HIV-1 Nef protein acts as a connector with sorting pathways in the golgi and at the plasma membrane. Immunity 6:67-77
154. 154. Marciniak R, Sharp PA. 1991. HIV-1 Tat protein promotes formation of more processive elongation complexes. EMBO J. 10:4189-96
155. 155. Margolis DM, Somasundaran M, Green MR. 1994. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production. J. Virol. 68:905-10
156. 156. Margottin F, Bour SP, Durand H, Selig L, Benichou S, et al. 1998. A novel human WD protein h-beta TrCp that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1:565-74
157. 157. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. 1997. Global distribution of the CCR5 gene 32-basepair deletion. Nat. Genet. 16:100-3
158. 158. Marzio G, Tyagi M, Gutierrez MI, Giacca M. 1998. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA 95:13519-24
159. 159. Masuda T, Kuroda MJ, Harada S. 1998. Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J. Virol. 72:8396-402
160. 160. Mattaj IW, Englmeier L. 1998. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67:265-306
161. 161. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, et al. 1997. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71:1692-96
162. 162. McMillan NA, Chun RF, Siderovsky DP, Galabru J, Toone WM, et al. 1995. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213:413-24
163. 163. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, et al. 1997. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3:338-40
164. 164. Miller MD, Farnet CM, Bushman FD. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:5382-90
165. 165. Mirkovitch J. 1997. The role of chromatin in HIV-1 transcriptional regulation. Immunobiology 198:279-90
166. 166. Moore JP, Ho DD. 1995. HIV-1 neutralization: the consequence of viral adaptation to growth on transformed T cells. AIDS 9(Suppl. A):S117-36
167. 167. Moore JP, Trkola A, Dragic T. 1997. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:551-62
168. 168. Moses AV, Ibanez C, Gaynor R, Ghazal P, Nelson JA. 1994. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J. Virol 68:298-307
169. 169. Musso T, Bosco MC, Longo DL, Espinoza-Delgado I, Sica A, et al. 1994. LPS-inducible nuclear factor in human monocytes that binds the negative regulatory element of the HIV LTR. J. Leukocyte Biol. 56:21-26
170. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682-86
171. 171. Nabel G, Baltimore D. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711-13
172. 172. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-67
173. 173. Neville M, Stutz F, Lee L, Davis LI, Rosbash M. 1997. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7:767-75
174. 174. Nie Z, Bergeron D, Subbramanian RA, Yao XJ, Checroune F, et al. 1998. The putative alpha helix of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72:4104-15
175. 175. Deleted in proof
176. 176. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, et al. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-35
177. 177. O'Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, et al. 1997. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349:1219
178. 178. O'Brien WA, Koyanagi Y, Namazie A, Zhao JQ, Diagne A, et al. 1990. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348:69-73
179. 179. Ogert RA, Lee LH, Beemon KL. 1996. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70:3834-43
180. 180. Ohno M, Shimura Y. 1996. A human RNA helicase-like protein HRH1 facilitates nuclear export of spliced mRNA by releasing the RNA from the spliceosome. Genes Dev. 10:997-1007
181. 181. Okamoto T, Bonter T, Josephs SF, Sadaie MR, Wong-Staal F. 1990. Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. Virology 177:606-14
182. 182. Ono Y, Ohno M, Shimura Y. 1994. Identification of a putative RNA helicase (HRH1) a human homolog of yeast Prp22. Mol. Cell. Biol. 14:7611-20
183. 183. Ossareh-Nazari B, Bachelerie F, Dargemont C. 1997. Evidence for a role of CRM-1 in signal-mediated nuclear protein export. Science 278:141-44
184. 184. Otero GC, Harris ME, Donello JE, Hope TJ. 1998. Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element. J. Virol. 7:7593-97
185. 185. Otero GC, Hope TJ. 1998. Splicing-independent expression of the herpes simplex virus type 1 thymidine kinase gene is mediated by three cis-acting RNA subelements. J. Virol. 72:9889-96
186. 186. Ou SH, Garcia-Martinez LF, Paulssen EJ, Gaynor RB. 1994. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J. Virol. 68:7188-99
187. 187. Parada CA, Yoon JB, Roeder RG. 1995. A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. J. Biol. Chem. 270:2274-83
188. 188. Deleted in proof
189. 189. Pasquinelli AE, Ernst RK, Lund E, Grimm C, Zapp Ml, et al. 1997. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16:7500-10
190. 190. Paxton WA, Dragic T, Koup RA, Moore JP. 1996. The beta-chemokines, HIV type 1 second receptors, and exposed uninfected persons. AIDS Res. Hum. Retroviruses 12:1203-7
191. 191. Pazin MJ, Sheridan PL, Cannon K, Cao Z, Keck JG, et al. 1996. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37-49
192. 192. Deleted in proof
193. 193. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate infected cell life-span and viral generation time. Science 271:1582-86
194. 194. Perkins ND, Agranoff AB, Duckett CS, Nabel GJ. 1994. Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression. J. Virol. 68:6820-23
195. 195. Piguet V, Chen YL, Mangasarian A, Foti M, Carpentier JL, et al. 1998 Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 17:2472-81
196. 196. Poeschla E, Corbeau P, Wong-Staal F. 1996. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA 93:11395-99
197. 197. Poeschla EM, Looney DJ. 1998. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J. Virol. 72:6858-66
198. 198. Poeschla EM, Wong-Staal F, Looney DJ. 1998. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4:354-57
199. 199. Poeschla E, Gilbert J, Li X, Huang S, Ho A, Wong-Staal F. 1998. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J. Virol. 72:6527-36
200. 200. Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M. 1998. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273(21):13347-52
201. 201. Popov S, Rexach M, Zybarth G, Reiling N, Lee MA, et al. 1998. Viral protein R regulates nuclear import of the HIV-1 preintegration complex. EMBO J. 17:909-17
202. 202. Powell DM, Amaral MC, Wu JY, Maniatis T, Greene WC. 1997. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing. Proc. Natl Acad. Sci. USA 94:973-78
203. 203. Re F, Braaten D, Franke EK, Luban J. 1995. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:6859-64
204. 204. Reddy EP, Dasgupta P. 1992. Regulation of HIV-1 gene expression by cellular transcription factors. Pathobiology 60:219-24
205. 205. Rittner K, Churcher MJ, Gait MJ, Karn J. 1995. The human immunodeficiency virus long terminal repeat includes a specialized initiator element which is required for Tat-responsive transcription. J. Mol. Biol. 248:562-80
206. 206. Rizzuto CD, Wyatt R, Hernández-Ramos N, Sun Y, Kwong PD, et al. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-53
207. 207. Roe T, Reynolds TC, Yu G, Brown PO. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-108
208. 208. Roebuck KA, Brenner DA, Kagnoff MF. 1993. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J. Clin. Invest. 92:1336-49
209. 209. Roy AL, Meisterernst M, Pognonec P, Roeder RG. 1991. Cooperative interaction of an initiator binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354:245-48
210. 210. Roy S, Agy M, Hovanessian AG, Sonenberg N, Katze MG. 1991. The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence RNA is required for the interaction with the interferon-induced 68,000-Mr protein kinase. J. Virol. 65:632-40
211. 211. Roy S, Parkin NT, Rosen C, Itovitch J, Sonenberg N. 1990. Structural requirements of transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base-pairing, loop sequences and bulges in the tat-responsive region. J. Virol 64:1402-6
212. 212. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, et al. 1997. Utilization of chemokine receptors, orphan receptors, and herpes-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71:8999-9007
213. 213. Ruhl M, Himmelspach M, Bahr GM, Hammerschmid F, Jaksche H, et al. 1993. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell Biol. 123:1309-20
214. 214. Saavedra C, Felber B, Izaurralde E. 1997. The simian retrovirus-1 constitutive transport element unlike the HIV-1 RRE uses factors required for cellular mRNA export. Curr. Biol. 7:619-28
215. 215. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard J, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-25
216. 216. Samuel CE. 1991. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11
217. 217. Samuel CE. 1993. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeast to humans. J. Biol. Chem. 268:7603-6
218. 218. Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S. 1998. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J. Biol. Chem. 273:20052-57
219. 219. Schatz O, Oft M, Dascher C, Schebesta M, Rosorius O, et al. 1998. Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5. Proc. Natl. Acad. Sci. USA 95:1607-12
220. 220. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede REY, et al. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-60
221. 221. Schwartz O, Marechal V, Danos O, Heard JM. 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:4053-59
222. 222. Schwartz O, Maréchal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-42
223. 223. Serizawa H, Conaway JW, Conaway RC. 1994. An oligomeric form of the large subunit of transcription factor (TF) IIE activates phosphorylation of the RNA polymerase II carboxyl-terminal domain by TFIIH. J. Biol. Chem. 269:20750-56
224. 224. Sheridan PL, Mayall TP, Verdin E, Jones KA. 1997. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11:3327-40
225. 225. Shieh JTC, Albright AV, Sharron M, Gartner S, Strizki J, et al. 1998. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J. Virol. 72:4243-49
226. 226. Shioda T, Levy JA, Cheng-Mayer C. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-69
227. 227. Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, et al. 1996. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:8355-60
228. 228. Simon JH, Gaddis NC, Fouchier RA, Malim MH. 1998. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4:1397-400
229. 229. Simon JHM, Malim MH. 1996. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70:5297-305
230. 230. Stade K, Ford CS, Guthrie C, Weis K. 1997. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90:1041-50
231. 231. Steger DJ, Workman JL. 1997. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J. 16:2463-72
232. 232. Streblow DN, Kitabwalla M, Malkovsky M, Pauza CD. 1998. Cyclophilin A modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. Virology 245:197-202
233. 233. Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, et al. 1998. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 187:1103-11
234. 234. Sullivan N, Sun Y, Sattentau Q, Thali M, Wu, D. 1998. CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:4694-703
235. 235. Sune C, Garcia-Blanco M. 1995. Sp1 transcription factor is required for in vivo basal and tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69:6572-76
236. 236. Swingler S, Morris A, Easton A. 1994. Tumor necrosis factor alpha and interleukin-1 beta induce specific subunits of NFKB to bind the HIV-1 enhancer: characterization of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. Biochem. Biophys. Res. Commun. 203:623-30
237. 237. Tabernero C, Zolotukhin AS, Bear J, Schneider R, Karsenty G, et al. 1997. Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. J. Virol. 71:95-101
238. 238. Tabernero C, Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK. 1996. The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J. Virol. 70:5998-11
239. 239. Tang H, Gaietta GM, Fischer WH, Ellisman MH, Wong-Staal F. 1997. A cellular cofactor for the constitutive transport element of type D retrovirus. Science 276:1412-15
240. 240. Tang H, McDonald D, Middlesworth T, Hope T, Wong-Staal F. 1999. The carboxyl terminus of RNA helicase A contains a bidirectional nuclear transport domain. Mol. Cell. Biol. In press
241. 241. Trkola A, Dragic T, Arthos J, Binley JM, Olson BW, et al. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-87
242. 242. Truant R, Cullen BR. 1999. The argininerich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell. Biol. 19:1210-17
243. 243. Ullman KS, Powers MA, Forbes DJ. 1997. Nuclear export receptors: from importin to exportin. Cell 90:967-70
244. 244. Vaishnav YN, Wong-Staal F. 1991. The biochemistry of AIDS. Annu. Rev. Biochem. 60:577-630
245. 245. Vallee H, Carre H. 1904. Sur la nature infectieuse de l'anemie du cheval. CR Acad. Sci. 139:331-33
246. 246. Van Lint C, Amella CA, Emiliani S, John M, Jie T, Verdin E. 1997. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 start site are important for virus infectivity. J. Virol. 71:6113-27
247. 247. Van Lint C, Emiliani S, Ott M, Verdin E. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1112-20
248. 248. Verdin E. 1991. DnaseI-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type-1. J. Virol. 65:6790-99
249. 249. Verdin E, Paras P Jr, Van Lint C. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249-59
250. 250. Veschambre P, Simard P, Jalinot P. 1995. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250:169-80
251. 251. Vodicka MA, Koepp DM, Silver PA, Emerman M. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:175-85
252. 252. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ. 1995. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270:25564-69
253. 253. Wang L, Mukherjee S, Narayan O, Zhao LJ. 1996. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1. Gene 178:7-13
254. 254. Waterman ML, Jones KA. 1990. Purification of TCF-aα, a T-cell specific transcription factor that activates the T-cell receptor Cα gene enhancer in a context-dependent manner. Nat. New Biol. 2:621-36
255. 255. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-62
256. 256. Weissenhorn W, Wharton SA, Calder LJ, Earl PL, Moss E, et al. 1996. The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J. 15:1507-14
257. 257. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, et al. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500
258. 258. Widlak P, Gaynor RB, Garrard WT. 1997. In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 and NFkappaB. J. Biol. Chem. 272:17654-61
259. 259. Wild CT, Dubay JW, Greenwell T, Baird T Jr, Oas TG, et al. 1994. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91:12676-80
260. 260. Willey RL, Maldarelli F, Martin MA, Strebel K. 1992. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:7193-200
261. 261. Wolff B, Sanglier JJ, Wang Y. 1997. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4:139-47
262. 262. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, et al. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-83
263. 263. Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, et al. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-11
264. 264. Xiao H, Lis JT, Jeang KT. 1997. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment. Mol. Cell. Biol. 17:6898-905
265. 265. Xu Y, Reddy TR, Fischer WH, Wong-Staal F. 1996. A novel hnRNP specifically interacts with HIV-1 RRE RNA. J. Biomed. Sci. 3:82-91
266. 266. Yang X, Gold MO, Tang DN, Lewis DE, Aguilar-Cordova E, et al. 1997. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94:12331-36
267. 267. Yang X, Herrmann CH, Rice AP. 1996. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:4576-84
268. 268. Yin L, Braaten D, Luban J. 1998. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J. Virol. 72:6430-36
269. 269. Yoo S, Myszka DG, Yeh C, McMurray M, Hill CP, Sundquist WI. 1997. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269:780-95
270. 270. Yoon JB, Li G, Roeder RG. 1994. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro. Mol. Cell. Biol. 14:1776-85
271. 271. Zhang L, Huang Y, He T, Cao Y, Ho DD. 1996. HIV-1 subtype and second receptor use. Nature 383:768
272. 272. Zhou Q, Sharp PA. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:321-28
273. 273. Zhu T, Mo H, Wang N, Nam DS, Cao Y, et al. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-81
274. 274. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, et al. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:2622-32
275. 275. Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK. 1994. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68: 7944-52